Deep Brain Stimulation for Cerebral Palsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new treatment method called Deep Brain Stimulation (DBS) to manage movement issues in children and young adults with cerebral palsy. DBS involves placing a device in the brain to send electrical signals to the cerebellum, aiming to improve movement symptoms. Participants must have a specific type of cerebral palsy with a history of brain injury and have found little relief from medication. The trial will test different stimulation settings to identify the most effective one for each participant. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially benefit from a novel treatment approach.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have a history of trying oral medications without adequate relief, so it's possible you may need to continue them.
What prior data suggests that this device is safe for treating movement symptoms related to cerebral palsy?
Research has shown that cerebellar deep brain stimulation (DBS) is generally safe for individuals with cerebral palsy. In studies involving patients with dystonic and spastic cerebral palsy, participants tolerated the treatment well. These studies included children and young adults, similar to those who might join the current trial. One study found that DBS significantly improved muscle stiffness in both arms and legs, suggesting it could help with movement issues.
No major safety concerns emerged in these studies, indicating the treatment is relatively safe, though individual reactions may vary. Prospective trial participants should discuss any concerns with a healthcare professional.12345Why are researchers excited about this trial?
Researchers are excited about cerebellar deep brain stimulation (DBS) for cerebral palsy because it offers a novel approach by directly targeting the brain's motor control regions. Unlike traditional therapies, such as physical therapy and muscle relaxants that primarily manage symptoms, DBS aims to enhance motor function by electrically stimulating the cerebellum. This innovative method could potentially improve movement and coordination more effectively and sustainably. Additionally, the ability to fine-tune stimulation settings for each individual means that treatment can be highly personalized, increasing the chances of meaningful improvements in quality of life for those with cerebral palsy.
What evidence suggests that Cerebellar Deep Brain Stimulation is effective for treating movement symptoms in cerebral palsy?
Research has shown that deep brain stimulation (DBS) can improve movement in individuals with movement disorders. In earlier studies, patients with cerebral palsy demonstrated better hand movements, coordination, walking, head control, and speech after receiving DBS. This trial will administer cerebellar DBS to all participants, targeting the cerebellum, which typically remains undamaged in cerebral palsy, making it a promising focus area. DBS has successfully treated other movement disorders by using electrical signals to control movement. This success suggests that DBS could also help manage movement symptoms in individuals with cerebral palsy.12456
Who Is on the Research Team?
Marta San Luciano Palenzuela
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for children and young adults aged 7-25 with dyskinetic cerebral palsy (DCP), who have tried oral medications without enough relief. They should be able to attend follow-up visits, have a history of brain injury before their motor symptoms started, and not have major cerebellar abnormalities on an MRI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Open-label Phase
Participants undergo an open label phase to titrate stimulation and determine optimal stimulation settings
Randomized Blinded Phase
Participants start three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cerebellar Deep Brain Stimulation
Cerebellar Deep Brain Stimulation is already approved in United States for the following indications:
- Dyskinetic cerebral palsy
- Movement disorders in cerebral palsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
National Institutes of Health (NIH)
Collaborator